
Surgical device maker AxoGen's shares AXGN.O rise 2.6% to $18.5 premarket
Co reports Q4 profit of 7 cents/share, beating analyst estimates of 3 cents/share, as per data compiled by LSEG
Co posts Q4 revenue of $49.4 mln vs analyst est of $48.6 mln
AXGN forecasts 2025 revenue growth of 15% to 17%
Stock has risen 72% in the past 12 months